Davies Philip D sold $563K of VICR

Davies Philip D (Corp. VP-Global Sales & Mktg.) sold 3,073 shares of VICOR CORP (VICR) at an average of $183.26 ($175.00–$192.07, $0.56M total) across 12 trades on 2026-11-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Davies Philip D
Published Nov 3, 2026, 4:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 4:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

This provides a fresh, company-specific datapoint on insider activity, but it does not indicate a change in business fundamentals or corporate strategy by itself.

02

Market read

Useful for monitoring insider behavior, but unlikely to drive a sustained repricing without additional catalysts.

03

What to watch

Traders may overreact to insider sales; without accompanying buys, guidance changes, or operational news, the signal is mostly sentiment-level.

Relevance 4/10Novelty 3/10Timing: SEC Form 4 filed Nov. 3, covering sales executed Nov. 2.

Background

The article is an SEC Form 4 insider transaction disclosure for ViCOR Corp, showing an open-market sale by an officer under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

ViCOR Corp insider Davies Philip D sold $563,164 of VICR shares via a Rule 10b5-1 plan, filing a Form 4 on Nov. 3.

Expected impact

Shares may face mild near-term sentiment pressure as traders note insider selling, but impact is likely limited given the pre-arranged 10b5-1 structure.

Evidence & confidence

The disclosure is a Form 4 open-market sale by a corporate VP, with a stated pre-arranged 10b5-1 plan; this typically reduces interpretive weight versus discretionary selling.

Market effects

No clear sector read-through from a single insider sale at this scale.

None.

None.

Counterpoint

Because the trades were executed under a pre-arranged 10b5-1 plan, the sale may be mechanically scheduled and not a bearish signal.

Key entities

  • VICOR CORP

    US-listed company whose insider sale is disclosed on Form 4.

  • Davies Philip D

    Corporate VP-Global Sales & Mktg., officer/director who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VICRMed

VICR SWOT Analysis: Strong Revenue Growth and Patent Settlement

Vicor Corp (VICR) reported Q3 2026 revenue of $197.1M, up 78.5% YoY, driven by product sales and royalty revenue. Gross margin increased to 68.3%. The company has a strong order backlog of $406M but faces valuation concerns and customer concentration risks. It has growth opportunities in EVs and renewable energy. VICR's GF Score is 82/100, with high growth and profitability ratings but low valuation.

$VICRHigh

VICR Stock Surges On Blowout Q3 And Aggressive Capacity Bet

Vicor Corporation (VICR) stock rose 12.95% after reporting Q3 2026 revenue of $197.1M, up 78.5% YoY, with gross margin at 68.3%. The company's backlog and operating cash flow increased, driven by AI and high-performance systems demand. VICR is expanding capacity and faces an ITC investigation. Analysts raised price targets to $350-$360.

$VICRHighAI 8/10

Why is Vicor stock climbing today?

Vicor Corporation (VICR) stock rose 2.6% in morning trading, extending gains after its Q3 2026 earnings beat expectations. Revenue was $197.1M, up 78.5% YoY, with adjusted EPS of $1.33. Gross margin expanded to 68.3%, and the order backlog grew 166% YoY to $406M. Analysts maintained Buy ratings with price targets of $350 and $375. The stock traded at $209.36, above its 52-week low of $79 but below its high of $382.65.